From Casetext: Smarter Legal Research

Bayer Schering Pharma AG v. Watson Pharms., Inc.

UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Mar 8, 2013
No. 2:08-cv-00995-KJD-(GWF) (D. Nev. Mar. 8, 2013)

Opinion

No. 2:08-cv-00995-KJD-(GWF) No. 2:07-cv-01472-KJD-(GWF)

03-08-2013

BAYER SCHERING PHARMA AG and BAYER HEALTHCARE PHARMACEUTICALS INC., Plaintiffs/Counter-Defendants, v. WATSON PHARMACEUTICALS, INC. and WATSON LABORATORIES, INC., Defendants/Counter-Plaintiffs, and SANDOZ INC., Defendant/Counter-Plaintiff.

Michael D. Rounds (Nevada Bar # 4734) Ryan E. Johnson (Nevada Bar # 9070) WATSON ROUNDS Mark T. Jansen (admitted pro hac vice ) CROWELL & MORING LLP Cedric C.Y. Tan (admitted pro hac vice ) Kristin M. Cooklin (admitted pro hac vice ) Neil McCarthy (admitted pro hac vice ) CROWELL & MORING LLP Counsel for Defendants/Counterclaim- Plaintiffs Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc.


Michael D. Rounds (Nevada Bar # 4734)
Ryan E. Johnson (Nevada Bar # 9070)
WATSON ROUNDS
Mark T. Jansen (admitted pro hac vice)
CROWELL & MORING LLP
Cedric C.Y. Tan (admitted pro hac vice)
Kristin M. Cooklin (admitted pro hac vice)
Neil McCarthy (admitted pro hac vice)
CROWELL & MORING LLP
Counsel for Defendants/Counterclaim-
Plaintiffs Watson Pharmaceuticals, Inc. and
Watson Laboratories, Inc.

ORDER DENYING AS MOOT

THE PORTION OF WATSON'S

EMERGENCY MOTION TO STAY

REQUESTING ALTERNATIVE RELIEF

UNDER FED. R. CIV. P. RULE 60(b)(6)

On February 11, 2013, this Court granted Plaintiff's Motion to Reset the Effective Date of the FDA's approval for the Defendants to Market Generic YAZ. (Dkt. 363.)

On February 12, 2013, Defendant Sandoz Inc. ("Sandoz") filed an emergency motion to stay the Court's February 11 order (see Dkt. 364.) and a memorandum in support thereof ("Emergency Motion to Stay"). Sandoz requested relief therein pursuant to Fed. R. Civ. P. 62(c) (Dkt. 364 at 2.) and, in the alternative, pursuant to Fed. R. Civ. P. 60(b)(6).

On February 13, 2013 Defendants Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. (collectively, "Watson") filed a joinder to Sandoz's Emergency Motion to Stay. (Dkt. 366.)

On February 28, 2013, Sandoz filed Notice of Withdrawal of the Portion of Sandoz's Emergency Motion to Stay Requesting Alternative Relief Under Fed. R. Civ. P. Rule 60(b)(6). (Dkt. 375.)

On February 28, 2013, Watson filed a Notice of Clarification and/or Partial Withdrawal of Watson's Notice and Joinder of Emergency Motion as to the Portion Requesting Alternative Relief Under Fed. R. Civ. P. 60(b)(6). (Dkt. 376.)

In view of the Watson notice of withdrawal as well as the Sandoz notice of withdrawal, IT IS HEREBY ORDERED that Watson's motion pursuant to Fed. R. Civ. P. 60(b)(6) is hereby DENIED as moot.

______________

Kent J. Dawson

United States District Judge


Summaries of

Bayer Schering Pharma AG v. Watson Pharms., Inc.

UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Mar 8, 2013
No. 2:08-cv-00995-KJD-(GWF) (D. Nev. Mar. 8, 2013)
Case details for

Bayer Schering Pharma AG v. Watson Pharms., Inc.

Case Details

Full title:BAYER SCHERING PHARMA AG and BAYER HEALTHCARE PHARMACEUTICALS INC.…

Court:UNITED STATES DISTRICT COURT DISTRICT OF NEVADA

Date published: Mar 8, 2013

Citations

No. 2:08-cv-00995-KJD-(GWF) (D. Nev. Mar. 8, 2013)